Omicron subvariant BA.2 becomes dominant strain in US, says CDC

The variant has been steadily rising in proportion due to its increased transmissibility compared to the original Omicron strain, Xinhua news agency reported.

covid
Photo: Unsplash/Fusion Medical Animation
IANS Los Angeles
1 min read Last Updated : Mar 30 2022 | 6:45 AM IST

The BA.2 sub-lineage of the Omicron variant has become the dominant strain in the United States, according to new data released by the US Centers for Disease Control and Prevention (CDC).

The variant has been steadily rising in proportion due to its increased transmissibility compared to the original Omicron strain, Xinhua news agency reported.

The BA.2 variant represented 54.9 per cent of new Covid-19 cases for the week ending March 26, according to CDC data.

This data is up from 39 per cent a week prior, and 27.8 per cent two weeks before.

The BA.2 subvariant is thought to be about 30 per cent more transmissible than the original BA.1 Omicron strain, early study suggested.

--IANS

int/shs

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Mar 30 2022 | 6:45 AM IST

Next Story